Annual Interest Expense
$1.30 M
-$4.10 M-75.91%
December 31, 2023
Summary
- As of February 7, 2025, PRQR annual interest expense is $1.30 million, with the most recent change of -$4.10 million (-75.91%) on December 31, 2023.
- During the last 3 years, PRQR annual interest expense has fallen by -$1.03 million (-44.10%).
- PRQR annual interest expense is now -75.91% below its all-time high of $5.41 million, reached on December 31, 2022.
Performance
PRQR Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Interest Expense
N/A
September 1, 2024
Summary
- PRQR quarterly interest expense is not available.
Performance
PRQR Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM Interest Expense
N/A
September 1, 2024
Summary
- PRQR TTM interest expense is not available.
Performance
PRQR TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Interest Expense Formula
Interest Expense = Carrying Value of Debt X Effective Interest Rate
PRQR Interest Expense Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -75.9% | - | - |
| 3 y3 years | -44.1% | - | - |
| 5 y5 years | +36.2% | - | - |
PRQR Interest Expense Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -75.9% | at low | ||||
| 5 y | 5-year | -75.9% | +7.4% | ||||
| alltime | all time | -75.9% | +2479.0% |
ProQR Therapeutics NV Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $1.30 M(-75.9%) | - | - |
| Dec 2022 | $5.41 M(+34.2%) | - | - |
| Dec 2021 | $4.03 M(+72.9%) | - | - |
| Dec 2020 | $2.33 M(+92.2%) | - | - |
| Dec 2019 | $1.21 M(+26.8%) | - | - |
| Dec 2018 | $956.50 K | $166.60 K(+93.7%) | $252.60 K(+193.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | $86.00 K | $86.00 K |
| Dec 2017 | $675.00 K(+13.4%) | - | - |
| Dec 2016 | $595.40 K(+35.8%) | - | - |
| Dec 2015 | $438.30 K(+24.4%) | - | - |
| Dec 2014 | $352.40 K(+597.8%) | - | - |
| Dec 2013 | $50.50 K | - | - |
FAQ
- What is ProQR Therapeutics NV annual interest expense?
- What is the all time high annual interest expense for ProQR Therapeutics NV?
- What is ProQR Therapeutics NV annual interest expense year-on-year change?
- What is the all time high quarterly interest expense for ProQR Therapeutics NV?
- What is the all time high TTM interest expense for ProQR Therapeutics NV?
What is ProQR Therapeutics NV annual interest expense?
The current annual interest expense of PRQR is $1.30 M
What is the all time high annual interest expense for ProQR Therapeutics NV?
ProQR Therapeutics NV all-time high annual interest expense is $5.41 M
What is ProQR Therapeutics NV annual interest expense year-on-year change?
Over the past year, PRQR annual interest expense has changed by -$4.10 M (-75.91%)
What is the all time high quarterly interest expense for ProQR Therapeutics NV?
ProQR Therapeutics NV all-time high quarterly interest expense is $166.60 K
What is the all time high TTM interest expense for ProQR Therapeutics NV?
ProQR Therapeutics NV all-time high TTM interest expense is $252.60 K